Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-037479
Filing Date
2014-12-01
Accepted
2014-12-01 09:03:24
Documents
1
Period of Report
2014-11-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd419446.html 4  
1 FORM 4 rrd419446.xml 4 3729
  Complete submission text file 0001181431-14-037479.txt   5096
Mailing Address C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE NOVATO CA 94949
Business Address
BAFFI ROBERT (Reporting) CIK: 0001274826 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35798 | Film No.: 141256457

Mailing Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Issuer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations